Advertisement

Leukocytospermia and Oxidative Stress

  • Margot Flint
  • Ashok Agarwal
  • Stefan S. du Plessis
Chapter
Part of the Oxidative Stress in Applied Basic Research and Clinical Practice book series (OXISTRESS)

Abstract

The invasion of microorganisms and infective bacteria in the genito-­urinary tract leads to the rapid increase in white blood cells, a condition referred to as leukocytospermia. This inflammatory response, aimed at killing the microorganisms via the production and release of reactive oxygen species (ROS), can result in pathologically high concentrations of ROS. When these concentrations greatly exceed the level required for normal physiological function, the natural defense system of scavenging antioxidants can be overwhelmed, resulting in oxidative stress (OS) thereby compromising the integrity of spermatozoa and functional parameters vital for successful fertilization. The complexity of OS is furthered when additional factors (e.g., smoking, varicocele) increase ROS levels in the male genito-urinary system. At present, the association between semen parameters and leukocyte concentrations is a focal point in the field of male reproductive science. This chapter aims at exploring the relationship between leukocytospermia, OS, the harmful effects on male reproductive potential, as well as possible treatment regimes.

Keywords

Leukocytospermia Oxidative stress Male genitalia tract infections Reactive oxygen species Leukocytes Antioxidants 

References

  1. 1.
    Ochsendorf FR. Infections in the male genital tract and reactive oxygen species. Hum Reprod Update. 1999;5(5):399–420.PubMedCrossRefGoogle Scholar
  2. 2.
    Sikka SC, Rajasekaran M, Hellstrom WJ. Role of oxidative stress and antioxidants in male infertility. J Androl. 1995;16(6):464–8.PubMedGoogle Scholar
  3. 3.
    Makker K, Agarwal A, Sharma R. Oxidative stress & male infertility. Indian J Med Res. 2009;129(4):357–67.PubMedGoogle Scholar
  4. 4.
    Aydemir B, et al. The influence of oxidative damage on viscosity of seminal fluid in infertile men. J Androl. 2008;29(1):41–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Desai N, et al. Physiologic and pathologic levels of reactive oxygen species in neat semen of infertile men. Fertil Steril. 2009;92(5):1626–31.PubMedCrossRefGoogle Scholar
  6. 6.
    Alvarez JG, et al. Increased DNA damage in sperm from leukocytospermic semen samples as determined by the sperm chromatin structure assay. Fertil Steril. 2002;78(2):319–29.PubMedCrossRefGoogle Scholar
  7. 7.
    Sharma RK, et al. Relationship between seminal white blood cell counts and oxidative stress in men treated at an infertility clinic. J Androl. 2001;22(4):575–83.PubMedGoogle Scholar
  8. 8.
    Keck C, et al. Seminal tract infections: impact on male fertility and treatment options. Hum Reprod Update. 1998;4(6):891–903.PubMedCrossRefGoogle Scholar
  9. 9.
    Lewis SE. Is sperm evaluation useful in predicting human fertility? Reproduction. 2007;134(1):31–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Pasqualotto FF, et al. Seminal oxidative stress in patients with chronic prostatitis. Urology. 2000;55(6):881–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Zorn B, et al. Semen polymorphonuclear neutrophil leukocyte elastase as a diagnostic and prognostic marker of genital tract inflammation—a review. Clin Chem Lab Med. 2003;41(1):2–12.PubMedCrossRefGoogle Scholar
  12. 12.
    Gdoura R, et al. Screening for bacterial pathogens in semen samples from infertile men with and without leukocytospermia. Andrologia. 2008;40(4):209–18.PubMedCrossRefGoogle Scholar
  13. 13.
    Lackner J, et al. Value of counting white blood cells (WBC) in semen samples to predict the presence of bacteria. Eur Urol. 2006;49(1):148–52; discussion 152–3.Google Scholar
  14. 14.
    Trum JW, et al. Value of detecting leukocytospermia in the diagnosis of genital tract infection in subfertile men. Fertil Steril. 1998;70(2):315–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Sanocka D, et al. Male genital tract inflammation: the role of selected interleukins in regulation of pro-oxidant and antioxidant enzymatic substances in seminal plasma. J Androl. 2003;24(3):448–55.PubMedGoogle Scholar
  16. 16.
    Politch JA, et al. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod. 2007;22(11):2928–35.PubMedCrossRefGoogle Scholar
  17. 17.
    el-Demiry MI, et al. Immunocompetent cells in human testis in health and disease. Fertil Steril. 1987;48(3):470–9.PubMedGoogle Scholar
  18. 18.
    World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: WHO Press; 2010. p. 271.Google Scholar
  19. 19.
    Kokab A, et al. Raised inflammatory markers in semen from men with asymptomatic chlamydial infection. J Androl. 2010;31(2):114–20.PubMedCrossRefGoogle Scholar
  20. 20.
    Weidner W, Krause W, Ludwig M. Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum Reprod Update. 1999;5(5):421–32.PubMedCrossRefGoogle Scholar
  21. 21.
    Vicari E. Seminal leukocyte concentration and related specific reactive oxygen species production in patients with male accessory gland infections. Hum Reprod. 1999;14(8):2025–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Eggert-Kruse W, et al. Clinical relevance of polymorphonuclear (PMN-) elastase determination in semen and serum during infertility investigation. Int J Androl. 2009;32(4):317–29.PubMedCrossRefGoogle Scholar
  23. 23.
    Micic S, et al. Elastase as an indicator of silent genital tract infection in infertile men. Int J Androl. 1989;12(6):423–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Jochum M, Pabst W, Schill WB. Granulocyte elastase as a sensitive diagnostic parameter of silent male genital tract inflammation. Andrologia. 1986;18(4):413–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Aziz N, et al. Novel associations between specific sperm morphological defects and leukocytospermia. Fertil Steril. 2004;82(3):621–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Gambera L, et al. Sperm quality and pregnancy rate after COX-2 inhibitor therapy of infertile males with abacterial leukocytospermia. Hum Reprod. 2007;22(4):1047–51.PubMedCrossRefGoogle Scholar
  27. 27.
    Kaleli S, et al. Does leukocytospermia associate with poor semen parameters and sperm functions in male infertility? The role of different seminal leukocyte concentrations. Eur J Obstet Gynecol Reprod Biol. 2000;89(2):185–91.PubMedCrossRefGoogle Scholar
  28. 28.
    Arata de Bellabarba G, et al. Nonsperm cells in human semen and their relationship with semen parameters. Arch Androl. 2000;45(3):131–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Aitken RJ, et al. Differential contribution of leucocytes and spermatozoa to the generation of reactive oxygen species in the ejaculates of oligozoospermic patients and fertile donors. J Reprod Fertil. 1992;94(2):451–62.PubMedCrossRefGoogle Scholar
  30. 30.
    de Lamirande E, Gagnon C. Capacitation-associated production of superoxide anion by human spermatozoa. Free Radic Biol Med. 1995;18(3):487–95.PubMedCrossRefGoogle Scholar
  31. 31.
    Cocuzza M, et al. Clinical relevance of oxidative stress and sperm chromatin damage in male infertility: an evidence based analysis. Int Braz J Urol. 2007;33(5):603–21.PubMedCrossRefGoogle Scholar
  32. 32.
    Saleh RA, et al. Leukocytospermia is associated with increased reactive oxygen species production by human spermatozoa. Fertil Steril. 2002;78(6):1215–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Aitken RJ, Buckingham D, Harkiss D. Use of a xanthine oxidase free radical generating system to investigate the cytotoxic effects of reactive oxygen species on human spermatozoa. J Reprod Fertil. 1993;97(2):441–50.PubMedCrossRefGoogle Scholar
  34. 34.
    Aitken RJ, Baker HW. Seminal leukocytes: passengers, terrorists or good samaritans? Hum Reprod. 1995;10(7):1736–9.PubMedGoogle Scholar
  35. 35.
    Aitken RJ, et al. Reactive oxygen species generation by human spermatozoa is induced by exogenous NADPH and inhibited by the flavoprotein inhibitors diphenylene iodonium and quinacrine. Mol Reprod Dev. 1997;47(4):468–82.PubMedCrossRefGoogle Scholar
  36. 36.
    Sanocka D, Kurpisz M. Reactive oxygen species and sperm cells. Reprod Biol Endocrinol. 2004;2:12.PubMedCrossRefGoogle Scholar
  37. 37.
    Fariello RM, et al. Effect of leukocytospermia and processing by discontinuous density gradient on sperm nuclear DNA fragmentation and mitochondrial activity. J Assist Reprod Genet. 2009;26(2–3):151–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Athayde KS, et al. Development of normal reference values for seminal reactive oxygen ­species and their correlation with leukocytes and semen parameters in a fertile population. J Androl. 2007;28(4):613–20.PubMedCrossRefGoogle Scholar
  39. 39.
    Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology. 1996;48(6):835–50.PubMedCrossRefGoogle Scholar
  40. 40.
    Aitken RJ, West K, Buckingham D. Leukocytic infiltration into the human ejaculate and its association with semen quality, oxidative stress, and sperm function. J Androl. 1994;15(4):343–52.PubMedGoogle Scholar
  41. 41.
    Shekarriz M, et al. Positive myeloperoxidase staining (Endtz test) as an indicator of excessive reactive oxygen species formation in semen. J Assist Reprod Genet. 1995;12(2):70–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Gavella M, Lipovac V. NADH-dependent oxidoreductase (diaphorase) activity and isozyme pattern of sperm in infertile men. Arch Androl. 1992;28(2):135–41.PubMedCrossRefGoogle Scholar
  43. 43.
    Agarwal A, Prabakaran SA. Mechanism, measurement, and prevention of oxidative stress in male reproductive physiology. Indian J Exp Biol. 2005;43(11):963–74.PubMedGoogle Scholar
  44. 44.
    Saleh RA, Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. J Androl. 2002;23(6):737–52.PubMedGoogle Scholar
  45. 45.
    Alkan I, et al. Reactive oxygen species production by the spermatozoa of patients with idiopathic infertility: relationship to seminal plasma antioxidants. J Urol. 1997;157(1):140–3.PubMedCrossRefGoogle Scholar
  46. 46.
    de Lamirande E, Gagnon C. Human sperm hyperactivation in whole semen and its association with low superoxide scavenging capacity in seminal plasma. Fertil Steril. 1993;59(6):1291–5.PubMedGoogle Scholar
  47. 47.
    Bansal AK, Biaspuri GS. Impacts of oxidative stress and antioxidants on semen functions. Vet Med Int. 2011;1(1):1–7.CrossRefGoogle Scholar
  48. 48.
    Sanocka D, et al. Oxidative stress and male infertility. J Androl. 1996;17(4):449–54.PubMedGoogle Scholar
  49. 49.
    Krause W, et al. Cellular and biochemical markers in semen indicating male accessory gland inflammation. Andrologia. 2003;35(5):279–82.PubMedGoogle Scholar
  50. 50.
    Ford WC, Whittington K, Williams AC. Reactive oxygen species in human sperm suspensions: production by leukocytes and the generation of NADPH to protect sperm against their effects. Int J Androl. 1997;20 Suppl 3:44–9.PubMedGoogle Scholar
  51. 51.
    Whittington K, Ford WC. Relative contribution of leukocytes and of spermatozoa to reactive oxygen species production in human sperm suspensions. Int J Androl. 1999;22(4):229–35.PubMedCrossRefGoogle Scholar
  52. 52.
    de Lamirande E, et al. Reactive oxygen species and sperm physiology. Rev Reprod. 1997;2(1):48–54.PubMedCrossRefGoogle Scholar
  53. 53.
    Acosta AA, Kruger TF, editors. Human spermatozoa in assisted reproduction. 2nd ed. Bath: Parthenon Publishing Group; 1996. p. 518.Google Scholar
  54. 54.
    Pasqualotto FF, et al. Oxidative stress in normospermic men undergoing infertility evaluation. J Androl. 2001;22(2):316–22.PubMedGoogle Scholar
  55. 55.
    Kokab A, et al. Raised inflammatory markers in semen from men with asymptomatic chlamydial infection. J Androl. 2010;31(2):114–20.PubMedCrossRefGoogle Scholar
  56. 56.
    Bezold G, et al. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril. 2007;87(5):1087–97.PubMedCrossRefGoogle Scholar
  57. 57.
    Esfandiari N, et al. Utility of the nitroblue tetrazolium reduction test for assessment of reactive oxygen species production by seminal leukocytes and spermatozoa. J Androl. 2003;24(6):862–70.PubMedGoogle Scholar
  58. 58.
    Blake DR, Allen RE, Lunec J. Free radicals in biological systems—a review orientated to inflammatory processes. Br Med Bull. 1987;43(2):371–85.PubMedGoogle Scholar
  59. 59.
    Plante M, de Lamirande E, Gagnon C. Reactive oxygen species released by activated neutrophils, but not by deficient spermatozoa, are sufficient to affect normal sperm motility. Fertil Steril. 1994;62(2):387–93.PubMedGoogle Scholar
  60. 60.
    Wolff H, et al. Impact of clinically silent inflammation on male genital tract organs as reflected by biochemical markers in semen. J Androl. 1991;12(5):331–4.PubMedGoogle Scholar
  61. 61.
    Lu JC, et al. Standardization and quality control for determination of fructose in seminal plasma. J Androl. 2007;28(2):207–13.PubMedCrossRefGoogle Scholar
  62. 62.
    Gonzales GF. Function of seminal vesicles and their role on male fertility. Asian J Androl. 2001;3(4):251–8.PubMedGoogle Scholar
  63. 63.
    Andrade-Rocha FT. Semen analysis in laboratory practice: an overview of routine tests. J Clin Lab Anal. 2003;17(6):247–58.PubMedCrossRefGoogle Scholar
  64. 64.
    Comhaire FH, et al. Mechanisms and effects of male genital tract infection on sperm quality and fertilizing potential: the andrologist’s viewpoint. Hum Reprod Update. 1999;5(5):393–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Comhaire FH, Vermeulen L, Pieters O. Study of the accuracy of physical and biochemical markers in semen to detect infectious dysfunction of the accessory sex glands. J Androl. 1989;10(1):50–3.PubMedGoogle Scholar
  66. 66.
    Kessopoulou E, et al. Origin of reactive oxygen species in human semen: spermatozoa or ­leucocytes? J Reprod Fertil. 1992;94(2):463–70.PubMedCrossRefGoogle Scholar
  67. 67.
    Ricci G, et al. Leukocyte detection in human semen using flow cytometry. Hum Reprod. 2000;15(6):1329–37.PubMedCrossRefGoogle Scholar
  68. 68.
    Henkel R, et al. Urogenital inflammation: changes of leucocytes and ROS. Andrologia. 2003;35(5):309–13.PubMedGoogle Scholar
  69. 69.
    Johanisson E, et al. Evaluation of ‘round cells’ in semen analysis: a comparative study. Hum Reprod Update. 2000;6(4):404–12.PubMedCrossRefGoogle Scholar
  70. 70.
    Maegawa M, et al. A repertoire of cytokines in human seminal plasma. J Reprod Immunol. 2002;54(1–2):33–42.PubMedCrossRefGoogle Scholar
  71. 71.
    Villegas J, et al. Indirect immunofluorescence using monoclonal antibodies for the detection of leukocytospermia: comparison with peroxidase staining. Andrologia. 2002;34(2):69–73.PubMedCrossRefGoogle Scholar
  72. 72.
    Wang A, et al. Generation of reactive oxygen species by leukocytes and sperm following exposure to urogenital tract infection. Arch Androl. 1997;39(1):11–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod. 1989;41(1):183–97.PubMedCrossRefGoogle Scholar
  74. 74.
    Tunc O, Thompson J, Tremellen K. Development of the NBT assay as a marker of sperm ­oxidative stress. Int J Androl. 2010;33(1):13–21.PubMedCrossRefGoogle Scholar
  75. 75.
    Sikka SC. Oxidative stress and role of antioxidants in normal and abnormal sperm function. Front Biosci. 1996;1:e78–86.PubMedGoogle Scholar
  76. 76.
    Miesel R, et al. Severe antioxidase deficiency in human semen samples with pathological spermiogram parameters. Andrologia. 1997;29(2):77–83.PubMedCrossRefGoogle Scholar
  77. 77.
    Lewis SE, et al. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril. 1995;64(4):868–70.PubMedGoogle Scholar
  78. 78.
    Agarwal A, et al. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online. 2004;8(6):616–27.PubMedCrossRefGoogle Scholar
  79. 79.
    Storey BT, Alvarez JG, Thompson KA. Human sperm glutathione reductase activity in situ reveals limitation in the glutathione antioxidant defense system due to supply of NADPH. Mol Reprod Dev. 1998;49(4):400–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Williams AC, Ford WC. Functional significance of the pentose phosphate pathway and glutathione reductase in the antioxidant defenses of human sperm. Biol Reprod. 2004;71(4):1309–16.PubMedCrossRefGoogle Scholar
  81. 81.
    Erenpreiss J, et al. Effect of leukocytospermia on sperm DNA integrity: a negative effect in abnormal semen samples. J Androl. 2002;23(5):717–23.PubMedGoogle Scholar
  82. 82.
    Agarwal A, Prabakaran SA, Said TM. Prevention of oxidative stress injury to sperm. J Androl. 2005;26(6):654–60.PubMedCrossRefGoogle Scholar
  83. 83.
    Siciliano L, et al. Impaired seminal antioxidant capacity in human semen with hyperviscosity or oligoasthenozoospermia. J Androl. 2001;22(5):798–803.PubMedGoogle Scholar
  84. 84.
    Showell MG, et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2011;(1):CD007411.Google Scholar
  85. 85.
    Irvine DS. Glutathione as a treatment for male infertility. Rev Reprod. 1996;1(1):6–12.PubMedCrossRefGoogle Scholar
  86. 86.
    Bucak MN, et al. Effects of antioxidants on post-thawed bovine sperm and oxidative stress parameters: antioxidants protect DNA integrity against cryodamage. Cryobiology. 2010;61(3):248–53.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Margot Flint
    • 1
  • Ashok Agarwal
    • 2
  • Stefan S. du Plessis
    • 1
  1. 1.Division of Medical PhysiologyStellenbosch UniversityTygerbergSouth Africa
  2. 2.Center for Reproductive MedicineCleveland Clinic, Lerner College of MedicineClevelandUSA

Personalised recommendations